Hemodynamic effects of nifedipine in congestive heart failure

Am J Cardiol. 1980 Sep;46(3):476-80. doi: 10.1016/0002-9149(80)90018-1.

Abstract

Nifedipine, a potent coronary vasodilator, was administered in a single sublingual dose of 20 mg to eight patients with mild to moderate congestive heart failure. Nifedipine produced a slight increase in heart rate (mean +/- standard error of the mean 73.3 +/- 3.2 versus 80.9 +/- 2.1 beats/min, p < 0.025) and an increase in cardiac index (from a control value of 3.51 +/- 0.22 to 4.06 +/- 0.31 liters/min per m2, p < 0.01). Arterial blood pressure decreased from 112.9 +/- 6.2/67.7 +/- 4.2 (mean 84.9 +/- 4.0) to 100.8 +/- 4.4/56.4 +/- 11.0 (mean 76.1 +/- 4.3) mm Hg (p < 0.01) and total systemic vascular resistance also decreased from a control value of 15.6 +/- 1.0 to 12.4 +/- 0.8 units (p < 0.01) after administration of nifedipine. These data suggest that nifedipine may be useful for vasodilation in congestive heart failure.

MeSH terms

  • Adult
  • Cardiac Output / drug effects
  • Female
  • Heart Failure / drug therapy*
  • Heart Rate / drug effects
  • Hemodynamics / drug effects*
  • Humans
  • Hydralazine / pharmacology
  • Hydralazine / therapeutic use
  • Male
  • Middle Aged
  • Nifedipine / pharmacology*
  • Nifedipine / therapeutic use
  • Pulmonary Artery / physiopathology
  • Pulmonary Edema / drug therapy
  • Pyridines / pharmacology*
  • Stroke Volume / drug effects
  • Vascular Resistance / drug effects

Substances

  • Pyridines
  • Hydralazine
  • Nifedipine